Nutrition-Associated Biomarkers in Predicting Intravenous Immunoglobulin Resistance and Coronary Artery Lesions in Kawasaki Disease: A Systematic Review and Meta-Analysis.

Ling Liu, Rui Chen, Hong Wang, Honglu Yu, Zeyu Ai, Xiaofei Zhang
Author Information
  1. Ling Liu: Department of Pediatrics China-Japan Union Hospital of Jilin University Changchun Jilin China.
  2. Rui Chen: Department of Pediatrics China-Japan Union Hospital of Jilin University Changchun Jilin China.
  3. Hong Wang: Department of Pediatrics China-Japan Union Hospital of Jilin University Changchun Jilin China.
  4. Honglu Yu: Department of Pediatrics China-Japan Union Hospital of Jilin University Changchun Jilin China.
  5. Zeyu Ai: Department of Pediatrics China-Japan Union Hospital of Jilin University Changchun Jilin China.
  6. Xiaofei Zhang: Department of Pediatrics China-Japan Union Hospital of Jilin University Changchun Jilin China. ORCID

Abstract

Several studies explored the associations of pre-albumin (PA)/albumin (ALB) and ALB-combined indicators (prognostic nutrition index [PNI], albumin-to-globulin ratio [AGR], bilirubin-to-albumin [BAR], and C-reactive protein/albumin ratio [CAR]) with intravenous immunoglobulin (IVIG) resistance and coronary artery lesions (CALs) in Kawasaki disease (KD) patients. However, the results were controversial. A meta-analysis was conducted to reconfirm their associations and predictive performance. Databases of PubMed, EMBASE, and the Cochrane library were searched. The pooled standardized mean difference (SMD) or odds ratios (ORs) assessed the association, while the pooled area under the receiver operating characteristic curve (AUC) evaluated the predictive power. Ninety-four studies were included. Overall and subgroup meta-analyses demonstrated lower ALB and higher CAR were associated with IVIG resistance (ALB: SMD = -0.61; OR = 0.83; CAR: SMD = 1.47; OR = 1.69) and CALs (ALB: SMD = -0.56; OR = 0.92; CAR: SMD = 0.52). PNI was reduced in IVIG-resistant (SMD = -0.82) and coronary artery aneurysm (SMD = -0.18) patients in subgroup analysis and high PNI predicted the decreased risk of CALs in overall analysis (OR = 0.82). ALB, CAR, and PNI were a good or fair biomarker for differentiating IVIG-resistant (CALs) from IVIG-sensitive (non-CALs) patients (AUC > 0.6 or > 0.7). PA (SMD = -0.72) and BAR (SMD = 1.10) were differential in IVIG-resistant, but not in CAL patients compared with controls. AGR was not associated with CALs ( > 0.05). In conclusion, ALB, CAR, PNI, PA, and BAR may represent promising biomarkers for the prediction of IVIG resistance and CALs in KD patients.

Keywords

References

  1. Front Cardiovasc Med. 2022 Apr 27;9:883067 [PMID: 35571210]
  2. Front Immunol. 2021 Apr 12;12:624802 [PMID: 33912155]
  3. Sci Rep. 2024 Jul 2;14(1):15232 [PMID: 38956281]
  4. Heart Vessels. 2021 Sep;36(9):1366-1373 [PMID: 33686555]
  5. BMC Med Res Methodol. 2006 Jul 12;6:31 [PMID: 16836745]
  6. Ital J Pediatr. 2023 Jun 25;49(1):78 [PMID: 37357258]
  7. Eur J Pediatr. 2007 Feb;166(2):131-7 [PMID: 16896641]
  8. Kardiol Pol. 2022;80(6):657-663 [PMID: 35380006]
  9. Korean Circ J. 2010 May;40(5):239-42 [PMID: 20514335]
  10. Pediatr Int. 2016 Mar;58(3):180-184 [PMID: 26222760]
  11. Circulation. 2006 Jun 6;113(22):2606-12 [PMID: 16735679]
  12. Sci Rep. 2019 Feb 11;9(1):1722 [PMID: 30742060]
  13. Korean Circ J. 2014 Nov;44(6):415-22 [PMID: 25469144]
  14. Int Immunopharmacol. 2023 Sep;122:110600 [PMID: 37423157]
  15. Biochem Biophys Res Commun. 2023 Jul 23;666:29-35 [PMID: 37172449]
  16. Clin Exp Med. 2019 Nov;19(4):457-462 [PMID: 31478099]
  17. Pediatr Cardiol. 2021 Dec;42(8):1799-1804 [PMID: 34173835]
  18. Acta Paediatr. 2018 Dec;107(12):2179-2184 [PMID: 29797463]
  19. Paediatr Int Child Health. 2018 Aug;38(3):209-212 [PMID: 29768976]
  20. J Pediatr. 2013 Jun;162(6):1205-9 [PMID: 23290510]
  21. Ital J Pediatr. 2018 Mar 9;44(1):33 [PMID: 29523168]
  22. Arch Dis Child. 2019 Mar;104(3):262-267 [PMID: 30026252]
  23. Clin Exp Med. 2022 Nov;22(4):621-628 [PMID: 35039938]
  24. Crit Care Med. 2003 Jan;31(1):187-94 [PMID: 12545014]
  25. World J Pediatr. 2020 Dec;16(6):607-613 [PMID: 32232677]
  26. PLoS One. 2018 Sep 4;13(9):e0202658 [PMID: 30180185]
  27. Eur J Epidemiol. 2010 Sep;25(9):603-5 [PMID: 20652370]
  28. BMC Pediatr. 2021 Sep 16;21(1):406 [PMID: 34530763]
  29. Clin Rheumatol. 2016 Nov;35(11):2771-2776 [PMID: 27491972]
  30. Medicine (Baltimore). 2020 Sep 4;99(36):e21974 [PMID: 32899036]
  31. Semin Nucl Med. 1978 Oct;8(4):283-98 [PMID: 112681]
  32. PLoS One. 2019 May 20;14(5):e0215665 [PMID: 31107862]
  33. Mediators Inflamm. 2021 Aug 13;2021:9914071 [PMID: 34434074]
  34. Pediatr Infect Dis J. 2013 Aug;32(8):e319-23 [PMID: 23446442]
  35. Int Immunopharmacol. 2022 Sep;110:108986 [PMID: 35764015]
  36. Arch Dis Child. 2015 Apr;100(4):366-8 [PMID: 25670405]
  37. Hosp Pediatr. 2019 Oct;9(10):749-756 [PMID: 31501220]
  38. PLoS One. 2022 Jan 27;17(1):e0263060 [PMID: 35085339]
  39. Front Pediatr. 2018 Dec 11;6:374 [PMID: 30619784]
  40. Pediatr Allergy Immunol. 2007 Jun;18(4):354-9 [PMID: 17584314]
  41. Pediatr Res. 2024 Mar;95(4):1041-1050 [PMID: 38040988]
  42. Korean Circ J. 2018 Jan;48(1):71-79 [PMID: 29171205]
  43. Eur J Pediatr. 2022 Oct;181(10):3607-3615 [PMID: 35925450]
  44. Pediatr Cardiol. 2003 Mar-Apr;24(2):122-6 [PMID: 12457252]
  45. J Pediatr. 2000 Aug;137(2):177-80 [PMID: 10931408]
  46. Korean J Pediatr. 2016 Oct;59(10):408-413 [PMID: 27826327]
  47. Pediatr Cardiol. 2011 Dec;32(8):1106-9 [PMID: 21487793]
  48. J Formos Med Assoc. 2016 May;115(5):350-5 [PMID: 25910931]
  49. Front Pediatr. 2019 Dec 11;7:514 [PMID: 31921727]
  50. Nutr Metab Cardiovasc Dis. 2022 May;32(5):1186-1194 [PMID: 35260308]
  51. J Am Heart Assoc. 2016 Sep 15;5(9): [PMID: 27633390]
  52. Pediatr Cardiol. 2012 Apr;33(4):513-20 [PMID: 22105492]
  53. FASEB J. 2021 Feb;35(2):e21365 [PMID: 33496031]
  54. Sci Rep. 2023 Jan 7;13(1):352 [PMID: 36611091]
  55. Klin Padiatr. 2022 Nov;234(6):382-387 [PMID: 35785802]
  56. J Epidemiol. 2020 Oct 5;30(10):429-435 [PMID: 31548437]
  57. Clin Pediatr (Phila). 2018 Sep;57(10):1148-1153 [PMID: 29486579]
  58. Turk J Pediatr. 2019;61(5):648-656 [PMID: 32104995]
  59. Pediatr Rheumatol Online J. 2021 Sep 25;19(1):147 [PMID: 34563210]
  60. Ann Med. 2022 Dec;54(1):442-453 [PMID: 35099338]
  61. Brain Behav Immun. 2017 Feb;60:346-360 [PMID: 27845194]
  62. Front Pediatr. 2019 Sep 26;7:374 [PMID: 31612117]
  63. Pediatr Rheumatol Online J. 2021 Mar 12;19(1):24 [PMID: 33712036]
  64. Int Immunopharmacol. 2020 Dec;89(Pt A):107037 [PMID: 33242833]
  65. Korean Circ J. 2016 Jul;46(4):542-9 [PMID: 27482264]
  66. Korean J Pediatr. 2016 Feb;59(2):80-90 [PMID: 26958067]
  67. Children (Basel). 2022 Oct 21;9(10): [PMID: 36291529]
  68. Rheumatol Int. 2016 Jul;36(7):905-10 [PMID: 27215220]
  69. Pediatr Investig. 2019 Mar 22;3(1):19-26 [PMID: 32851284]
  70. BMC Pediatr. 2020 May 11;20(1):203 [PMID: 32393306]
  71. J Trop Pediatr. 2005 Apr;51(2):98-101 [PMID: 15677370]
  72. J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):705 [PMID: 22038366]
  73. PLoS One. 2016 Dec 21;11(12):e0167434 [PMID: 28002448]
  74. Front Pediatr. 2020 Nov 25;8:607631 [PMID: 33324592]
  75. J Pediatr. 2011 May;158(5):831-835.e3 [PMID: 21168857]
  76. Front Pediatr. 2022 Dec 13;10:979026 [PMID: 36582508]
  77. J Atheroscler Thromb. 2011;18(5):403-12 [PMID: 21350306]
  78. BMC Pediatr. 2017 Jun 6;17(1):139 [PMID: 28587647]
  79. J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):25-29 [PMID: 28062554]
  80. Ann Cardiol Angeiol (Paris). 2018 Apr;67(2):82-90 [PMID: 29544976]
  81. Biochem J. 1972 Oct;129(4):805-9 [PMID: 4655817]
  82. Int J Rheum Dis. 2013 Apr;16(2):168-72 [PMID: 23773640]
  83. Clin Rheumatol. 2023 Jan;42(1):145-150 [PMID: 36053472]
  84. BMJ. 1997 Sep 13;315(7109):629-34 [PMID: 9310563]
  85. Iran J Basic Med Sci. 2015 Jun;18(6):610-5 [PMID: 26221486]
  86. Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2289-94 [PMID: 16151018]
  87. PLoS One. 2017 May 23;12(5):e0176957 [PMID: 28542183]
  88. BMC Pediatr. 2020 Aug 24;20(1):398 [PMID: 32838756]
  89. Korean Circ J. 2011 Jul;41(7):379-84 [PMID: 21860639]
  90. Front Pediatr. 2022 Aug 23;10:969502 [PMID: 36081627]
  91. Eur J Pediatr. 2009 Nov;168(11):1315-21 [PMID: 19159953]
  92. Eur J Pediatr. 2002 Feb;161(2):105-11 [PMID: 11954744]
  93. Chin Med J (Engl). 2016 Apr 20;129(8):922-8 [PMID: 27064036]
  94. Front Nutr. 2023 Feb 01;10:1075619 [PMID: 36819679]
  95. J Pediatr. 2006 Aug;149(2):237-40 [PMID: 16887442]
  96. Acta Paediatr Jpn. 1991 Dec;33(6):805-10 [PMID: 1801561]
  97. Korean Circ J. 2014 Sep;44(5):328-35 [PMID: 25278986]
  98. Eur J Pediatr. 2023 Sep;182(9):4049-4057 [PMID: 37394531]
  99. Ther Apher Dial. 2015 Apr;19(2):171-7 [PMID: 25257673]
  100. Pediatr Infect Dis J. 2019 Jan;38(1):89-94 [PMID: 29601451]
  101. Pediatr Res. 2024 Jan;95(1):267-274 [PMID: 37670043]
  102. Eur J Intern Med. 2018 Jun;52:8-12 [PMID: 29680174]
  103. Expert Rev Clin Immunol. 2024 Sep;20(9):1127-1133 [PMID: 39072430]
  104. Rev Lat Am Enfermagem. 2016 Aug 08;24:e2736 [PMID: 27508908]
  105. Clin Rheumatol. 2019 Apr;38(4):1099-1107 [PMID: 30523553]
  106. Am J Cardiol. 1999 Feb 1;83(3):337-9 [PMID: 10072219]
  107. Front Pediatr. 2022 Mar 31;10:854079 [PMID: 35433542]
  108. Clin Pediatr (Phila). 2018 Feb;57(2):189-192 [PMID: 28952328]
  109. Korean J Pediatr. 2018 May;61(5):160-166 [PMID: 29853941]
  110. J Pediatr Pharmacol Ther. 2022;27(7):669-676 [PMID: 36186240]
  111. J Formos Med Assoc. 2023 Oct;122(10):1001-1007 [PMID: 37142476]
  112. Clin Chim Acta. 2020 Aug;507:264-270 [PMID: 32387635]
  113. Clin Exp Med. 2020 Feb;20(1):21-30 [PMID: 31734766]
  114. J Investig Med. 2021 Jan;69(1):13-19 [PMID: 33004469]
  115. Pediatr Cardiol. 2003 Mar-Apr;24(2):145-8 [PMID: 12457253]
  116. Circulation. 2003 Jul 22;108(3):325-30 [PMID: 12835221]
  117. J Formos Med Assoc. 2021 Oct;120(10):1884-1889 [PMID: 33358267]
  118. Front Pediatr. 2022 Apr 20;10:812644 [PMID: 35515347]
  119. EBioMedicine. 2022 Apr;78:103946 [PMID: 35306339]
  120. Front Cardiovasc Med. 2023 Jul 28;10:1226592 [PMID: 37576105]
  121. Acta Paediatr. 2010 Oct;99(10):1578-83 [PMID: 20491705]
  122. Exp Ther Med. 2020 Apr;19(4):2597-2603 [PMID: 32256739]
  123. J Trop Pediatr. 2016 Apr;62(2):86-93 [PMID: 26884440]
  124. Int J Cardiol. 2016 Jul 1;214:209-15 [PMID: 27070994]
  125. Stat Med. 2007 Nov 10;26(25):4544-62 [PMID: 17476644]
  126. Korean J Pediatr. 2016 Apr;59(4):178-82 [PMID: 27186228]
  127. Korean J Pediatr. 2013 Feb;56(2):75-9 [PMID: 23482814]
  128. Diagnostics (Basel). 2024 Jun 12;14(12): [PMID: 38928644]
  129. Microbes Infect. 2023 Sep-Oct;25(7):105168 [PMID: 37295770]
  130. Clin Rheumatol. 2023 Jan;42(1):167-177 [PMID: 36129563]
  131. Pediatr Rheumatol Online J. 2017 Mar 21;15(1):17 [PMID: 28320400]
  132. Front Pediatr. 2020 Apr 21;8:187 [PMID: 32373568]
  133. Pediatr Cardiol. 2012 Feb;33(2):272-9 [PMID: 21965088]
  134. Clin Cardiol. 2023 Nov;46(11):1434-1441 [PMID: 37540643]
  135. Scand J Rheumatol. 2015 May;44(3):247-52 [PMID: 25351965]
  136. Front Pediatr. 2020 Apr 07;8:148 [PMID: 32318530]
  137. Crit Care Med. 2003 Sep;31(9):2355-63 [PMID: 14501967]
  138. Front Cardiovasc Med. 2022 Sep 09;9:969495 [PMID: 36158849]
  139. Medicina (Kaunas). 2022 May 30;58(6): [PMID: 35743997]
  140. J Immunol Res. 2023 Aug 9;2023:6808323 [PMID: 37592925]
  141. Front Nutr. 2021 Sep 29;8:725537 [PMID: 34660661]
  142. Front Public Health. 2022 May 05;10:817613 [PMID: 35602151]

Word Cloud

Created with Highcharts 10.0.0CALspatientsSMD = -0ALBresistancePNIPAIVIGcoronaryarteryKawasakiCAROR = 0IVIG-resistantstudiesassociationsnutritionratiointravenousimmunoglobulinlesionsdiseaseKDpredictivepooledsubgroupassociatedALB:CAR:SMD = 182analysisBARSeveralexploredpre-albumin/albuminALB-combinedindicatorsprognosticindex[PNI]albumin-to-globulin[AGR]bilirubin-to-albumin[BAR]C-reactiveprotein/albumin[CAR]Howeverresultscontroversialmeta-analysisconductedreconfirmperformanceDatabasesPubMedEMBASECochranelibrarysearchedstandardizedmeandifferenceSMDoddsratiosORsassessedassociationareareceiveroperatingcharacteristiccurveAUCevaluatedpowerNinety-fourincludedOverallmeta-analysesdemonstratedlowerhigher618347OR = 1695692SMD = 052reducedaneurysm18highpredicteddecreasedriskoverallgoodfairbiomarkerdifferentiatingIVIG-sensitivenon-CALsAUC > 06> 077210differentialCALcomparedcontrolsAGR > 005conclusionmayrepresentpromisingbiomarkerspredictionNutrition-AssociatedBiomarkersPredictingIntravenousImmunoglobulinResistanceCoronaryArteryLesionsDisease:SystematicReviewMeta-Analysis

Similar Articles

Cited By